Rights and permissions
About this article
Cite this article
Docetaxel/estramustine increases survival in advanced prostate cancer. Inpharma Wkly. 1459, 13 (2004). https://doi.org/10.2165/00128413-200414590-00033
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414590-00033